Annual Operating Expenses
$107.70 M
-$46.80 M-30.29%
December 31, 2023
Summary
- As of February 7, 2025, CTMX annual total operating expenses is $107.70 million, with the most recent change of -$46.80 million (-30.29%) on December 31, 2023.
- During the last 3 years, CTMX annual operating expenses has fallen by -$41.27 million (-27.70%).
- CTMX annual operating expenses is now -36.04% below its all-time high of $168.38 million, reached on December 31, 2019.
Performance
CTMX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$29.32 M
-$4.25 M-12.65%
September 30, 2024
Summary
- As of February 7, 2025, CTMX quarterly total operating expenses is $29.32 million, with the most recent change of -$4.25 million (-12.65%) on September 30, 2024.
- Over the past year, CTMX quarterly operating expenses has increased by +$6.06 million (+26.05%).
- CTMX quarterly operating expenses is now -44.03% below its all-time high of $52.39 million, reached on March 31, 2020.
Performance
CTMX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
CTMX Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -30.3% | +26.1% |
| 3 y3 years | -27.7% | +26.1% |
| 5 y5 years | -21.6% | +26.1% |
CTMX Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -30.3% | at low | -36.3% | +26.1% |
| 5 y | 5-year | -36.0% | at low | -44.0% | +26.1% |
| alltime | all time | -36.0% | +579.7% | -44.0% | +445.1% |
CytomX Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $29.32 M(-12.6%) |
| Jun 2024 | - | $33.57 M(+12.6%) |
| Mar 2024 | - | $29.81 M(+9.5%) |
| Dec 2023 | $107.70 M(-30.3%) | $27.21 M(+17.0%) |
| Sep 2023 | - | $23.26 M(-17.1%) |
| Jun 2023 | - | $28.07 M(-3.7%) |
| Mar 2023 | - | $29.15 M(-1.6%) |
| Dec 2022 | $154.50 M(+0.7%) | $29.63 M(-27.5%) |
| Sep 2022 | - | $40.86 M(-4.8%) |
| Jun 2022 | - | $42.91 M(+4.4%) |
| Mar 2022 | - | $41.10 M(-10.7%) |
| Dec 2021 | $153.35 M(+2.9%) | $46.03 M(+14.4%) |
| Sep 2021 | - | $40.23 M(+13.3%) |
| Jun 2021 | - | $35.49 M(+12.3%) |
| Mar 2021 | - | $31.60 M(+1.4%) |
| Dec 2020 | $148.97 M(-11.5%) | $31.15 M(-4.7%) |
| Sep 2020 | - | $32.68 M(-0.2%) |
| Jun 2020 | - | $32.75 M(-37.5%) |
| Mar 2020 | - | $52.39 M(+14.7%) |
| Dec 2019 | $168.38 M | $45.66 M(+25.3%) |
| Sep 2019 | - | $36.43 M(-9.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $40.25 M(-12.6%) |
| Mar 2019 | - | $46.05 M(+23.5%) |
| Dec 2018 | $137.38 M(+16.5%) | $37.28 M(+4.5%) |
| Sep 2018 | - | $35.69 M(+3.2%) |
| Jun 2018 | - | $34.59 M(+16.0%) |
| Mar 2018 | - | $29.81 M(+5.3%) |
| Dec 2017 | $117.88 M(+58.0%) | $28.32 M(-19.5%) |
| Sep 2017 | - | $35.17 M(+3.1%) |
| Jun 2017 | - | $34.13 M(+68.4%) |
| Mar 2017 | - | $20.27 M(-1.1%) |
| Dec 2016 | $74.63 M(+82.4%) | $20.50 M(+11.6%) |
| Sep 2016 | - | $18.37 M(+5.9%) |
| Jun 2016 | - | $17.35 M(-5.7%) |
| Mar 2016 | - | $18.41 M(+36.2%) |
| Dec 2015 | $40.91 M(+17.4%) | $13.51 M(+2.3%) |
| Sep 2015 | - | $13.21 M(+74.1%) |
| Jun 2015 | - | $7.58 M(+14.8%) |
| Mar 2015 | - | $6.61 M(+1.4%) |
| Dec 2014 | $34.84 M(+119.9%) | $6.52 M(+21.2%) |
| Sep 2014 | - | $5.38 M |
| Dec 2013 | $15.84 M | - |
FAQ
- What is CytomX Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for CytomX Therapeutics?
- What is CytomX Therapeutics annual operating expenses year-on-year change?
- What is CytomX Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for CytomX Therapeutics?
- What is CytomX Therapeutics quarterly operating expenses year-on-year change?
What is CytomX Therapeutics annual total operating expenses?
The current annual operating expenses of CTMX is $107.70 M
What is the all time high annual operating expenses for CytomX Therapeutics?
CytomX Therapeutics all-time high annual total operating expenses is $168.38 M
What is CytomX Therapeutics annual operating expenses year-on-year change?
Over the past year, CTMX annual total operating expenses has changed by -$46.80 M (-30.29%)
What is CytomX Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of CTMX is $29.32 M
What is the all time high quarterly operating expenses for CytomX Therapeutics?
CytomX Therapeutics all-time high quarterly total operating expenses is $52.39 M
What is CytomX Therapeutics quarterly operating expenses year-on-year change?
Over the past year, CTMX quarterly total operating expenses has changed by +$6.06 M (+26.05%)